Holding Hands: Using Peptide-Drug Conjugates (PDCs) for the Precise Treatment of Pulmonary Fibrosis
Targeted therapy is a new paradigm in biomedical research that improves therapeutic efficacy, overcomes drug resistance, reduces off-target effects, and enables early disease detection by precisely delivering drugs to diseased tissue. Peptide drug conjugates (PDCs), a new tool for targeted therapy, consist of a targeting peptide, a linker, and an active drug. Dr Kelly's team […]